T. Olofsson

发表

Patient‐Reported Outcomes Are More Important Than Objective Inflammatory Markers for Sick Leave in Biologics‐Treated Patients With Rheumatoid Arthritis

L. Kristensen, J. Söderling, J. Wallman, 2018, Arthritis care & research.

Predictors of work disability after start of anti-TNF therapy in a national cohort of Swedish patients with rheumatoid arthritis: does early anti-TNF therapy bring patients back to work?

M. Neovius, C. Turesson, M. Englund, 2017, Annals of the rheumatic diseases.

Does disease activity at start of biologic therapy influence work-loss in RA patients?

M. Neovius, J. Askling, I. Petersson, 2016, Rheumatology.

How good is the agreement between clinical diagnoses and classification criteria fulfilment in axial spondyloarthritis? Results from the SPARTAKUS cohort

M. Geijer, A. Jöud, E. Lindqvist, 2022, Scandinavian journal of rheumatology.

Gut dysbiosis associated with worse disease activity and physical function in axial spondyloarthritis

M. Geijer, E. Lindqvist, L. Kristensen, 2022, Arthritis Research & Therapy.

Elevated faecal calprotectin is linked to worse disease status in axial spondyloarthritis: results from the SPARTAKUS cohort.

M. Geijer, E. Lindqvist, L. Kristensen, 2019, Rheumatology.

Work disability in non-radiographic axial spondyloarthritis patients before and after start of anti-TNF therapy: a population-based regional cohort study from southern Sweden

H. Bliddal, A. Jöud, L. Kristensen, 2017, Rheumatology.

Consultation prevalence among children, adolescents and young adults with pain conditions: A description of age‐ and gender differences

A. Jöud, T. Olofsson, E. Bondesson, 2019, European journal of pain.

Prime-boost vaccination strategy enhances immunogenicity compared to single pneumococcal conjugate vaccination in patients receiving conventional DMARDs, to some extent in abatacept but not in rituximab-treated patients

G. Jönsson, M. Kapetanovic, P. Nived, 2020, Arthritis Research & Therapy.

Predictors of unacceptable pain with and without low inflammation over 5 years in early rheumatoid arthritis—an inception cohort study

C. Turesson, L. Jacobsson, S. Bergman, 2021, Arthritis Research & Therapy.

Pain Over Two Years After Start of Biologic Versus Conventional Combination Treatment in Early Rheumatoid Arthritis: Results From a Swedish Randomized Controlled Trial

S. Saevarsdottir, J. Lampa, A. Jöud, 2020, Arthritis care & research.

Health-Care and Societal Costs Associated with Non-Persistence with Subcutaneous TNF-α Inhibitors in the Treatment of Inflammatory Arthritis (IA): A Retrospective Observational Study

J. Dalén, Z. Qureshi, A. Puenpatom, 2021, Advances in Therapy.

Anterior uveitis in patients with spondyloarthritis treated with secukinumab or tumour necrosis factor inhibitors in routine care: does the choice of biological therapy matter?

L. Jacobsson, J. Askling, B. Glintborg, 2021, Annals of the Rheumatic Diseases.

OP0133 Unacceptable, refractory pain despite inflammation control in early rheumatoid arthritis and its relation to treatment strategy: results from the randomised controlled swefot trial

S. Saevarsdottir, J. Lampa, A. Jöud, 2018, THURSDAY, 14 JUNE 2018.

Biological treatment of ankylosing spondylitis: a nationwide study of treatment trajectories on a patient level in clinical practice

J. Askling, T. Olofsson, U. Lindström, 2019, Arthritis Research & Therapy.

Elevated fecal levels of the inflammatory biomarker calprotectin in early systemic sclerosis

E. Lindqvist, J. Wallman, T. Olofsson, 2022, Rheumatology International.

OP0014 COMPARISON OF ANTERIOR UVEITIS OCCURRENCE DURING TREATMENT WITH SECUKINUMAB, ADALIMUMAB, INFLIXIMAB AND ETANERCEPT IN SPONDYLOARTHRITIS

L. Jacobsson, D. D. Giuseppe, J. Askling, 2020, Annals of the Rheumatic Diseases.

Characteristics associated with poor COVID-19 outcomes in people with psoriasis, psoriatic arthritis and axial spondyloarthritis: data from the COVID-19 PsoProtect and Global Rheumatology Alliance physician-reported registries

J. Yazdany, L. Carmona, N. Dand, 2023, Annals of the Rheumatic Diseases.

Chronic Pain and Assessment of Pain Sensitivity in Patients With Axial Spondyloarthritis: Results From the SPARTAKUS Cohort

A. Bremander, S. Bergman, E. Lindqvist, 2020, The Journal of Rheumatology.

Predictors of work disability during the first 3 years after diagnosis in a national rheumatoid arthritis inception cohort

M. Neovius, L. Jacobsson, M. Englund, 2013, Annals of the rheumatic diseases.

Decrease in sick leave among patients with rheumatoid arthritis in the first 12 months after start of treatment with tumour necrosis factor antagonists: a population-based controlled cohort study

L. Jacobsson, M. Englund, P. Geborek, 2010, Annals of the rheumatic diseases.

Impact of extra-articular spondyloarthritis manifestations and comorbidities on drug retention of a first TNF-inhibitor in ankylosing spondylitis: a population-based nationwide study

J. Askling, T. Olofsson, U. Lindström, 2018, RMD Open.

THU0597 Work Disability in Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis Before and After Start of Anti-Tnf Therapy: A Swedish Observational Study

H. Bliddal, A. Jöud, L. Kristensen, 2015 .

Costs in Relation to Disability, Disease Activity, and Health-related Quality of Life in Rheumatoid Arthritis: Observational Data from Southern Sweden

M. Neovius, P. Geborek, J. Nilsson, 2016, The Journal of Rheumatology.

Joint tenderness at 3 months follow-up better predicts long-term pain than baseline characteristics in early rheumatoid arthritis patients.

C. Turesson, S. Bergman, T. Mandl, 2023, Rheumatology.

Radiographic damage in early rheumatoid arthritis is associated with increased disability but not with pain—a 5-year follow-up study

C. Turesson, S. Bergman, T. Mandl, 2023, Arthritis Research & Therapy.

Sustained Remission in Patients With Rheumatoid Arthritis Receiving Triple Therapy Compared to Biologic Therapy: A Swedish Nationwide Register Study

P. Geborek, T. Saxne, J. Nilsson, 2021, Arthritis & rheumatology.

OP0249 CHARACTERISTICS ASSOCIATED WITH POOR COVID-19 OUTCOMES IN PEOPLE WITH PSORIASIS AND SPONDYLOARTHRITIS: DATA FROM THE COVID-19 PsoProtect AND GLOBAL RHEUMATOLOGY ALLIANCE PHYSICIAN-REPORTED REGISTRIES

M. Gianfrancesco, J. Yazdany, J. Hausmann, 2022, Annals of the Rheumatic Diseases.

Identifying Predictors of First-Line Subcutaneous TNF-Inhibitor Persistence in Patients with Inflammatory Arthritis: A Decision Tree Analysis by Indication

J. Dalén, E. Hernlund, A. Svedbom, 2023, Advances in Therapy.

Patient-reported outcomes in axial spondyloarthritis and psoriatic arthritis patients treated with secukinumab for 24 months in daily clinical practice.

D. D. Giuseppe, B. Gudbjornsson, F. Iannone, 2024, Seminars in Arthritis & Rheumatism.

Decrease in sick leave among patients with rheumatoid arthritis in the first 12 months after start of treatment with tumour necrosis factor antagonists: a population-based controlled cohort study

L. Jacobsson, M. Englund, P. Geborek, 2010, Annals of the Rheumatic Diseases.

Methotrexate treatment in early psoriatic arthritis in comparison to rheumatoid arthritis: an observational nationwide study

L. Jacobsson, J. Askling, J. Wallman, 2023, RMD Open.